BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Hematopoietic cell
,
Bleomycin
,
rs3825942
,
SLC12A1
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tak 1
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Dendritic (plasmacytoid) cell
Basophil of peripheral blood
T Lymphocyte (regulatory) of peripheral blood
Superior cervical ganglion
Corpus callosum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Ataxia-telangiectasia syndrome
Intestinal infectious disease
Chronic fatigue syndrome
Placental insufficiency
Disorder of uterus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
moroxydine
Aminocaproic Acids
Doxylamine
Ions
Prazosin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR448
TICAM1
RAC1
CNOT3
GATA5
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Innate immune signaling in Drosophila is regulated by transforming growth factor β (TGFβ)-activated …
Loss of Trabid, a new negative regulator of the drosophila immune-deficiency pathway at the level of…
Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia.
Post-Translational Modifications of the TAK1-TAB Complex.
Structure-guided development of covalent TAK1 inhibitors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study
A Phase 1/2 Study of TAK-788 in Japanese Patients
Phase 1, TAK-648, Single-Rising Dose Study
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ